SCHEMBL7082247

SCHEMBL7082247

Cc1c(C)c(Nc2ccc(C(=O)c3sccc3Cl)c(Cl)c2)c(C)c(C)c1Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 11/20 0.42
MAPK12 P53778 11/20 0.42
MAPK11 Q15759 11/20 0.42
MAPK14 Q16539 11/20 0.42
F10 P00742 2/20 0.39
MAPT P10636 3/20 0.37
ALDH1A1 P00352 2/20 0.37
GAA P10253 2/20 0.37
AGTR1 P30556 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
KMT2A Q03164 2/20 0.35
HTT P42858 1/20 0.35
APEX1 P27695 1/20 0.35
PKM P14618 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RORB Q92753 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7082583 0.86 RAPGEF4 (0.35) MAPK13MAPK12MAPK11MAPK14F10
SCHEMBL7075002 0.84 F10 (0.35) MAPK13MAPK12MAPK11MAPK14F10
SCHEMBL7075000 0.84 F10 (0.35) MAPK13MAPK12MAPK11MAPK14F10
SCHEMBL7074414 0.80 MAPK13 (0.53) MAPK13MAPK12MAPK11MAPK14F10
SCHEMBL7074410 0.80 MAPK13 (0.55) MAPK13MAPK12MAPK11MAPK14F10
SCHEMBL7079677 0.78 MAPK13 (0.60) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL7080479 0.78 MAPK13 (0.50) MAPK13MAPK12MAPK11MAPK14F10
SCHEMBL7082261 0.78 MAPK14 (0.70) MAPK13MAPK12MAPK11MAPK14F10
SCHEMBL7082323 0.75 MAPK14 (0.64) MAPK13MAPK12MAPK11MAPK14F10
SCHEMBL7080344 0.73 MAPK14 (0.68) MAPK13MAPK12MAPK11MAPK14RORB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US claimed
WO-2002083622-A2 NOVEL AMINOPHENYL KETONE DERIVATIVES LEO PHARMA A/S (DK) 2002-10-24 WO claimed
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed
WO-2002083622-A2 NOVEL AMINOPHENYL KETONE DERIVATIVES LEO PHARMA A/S (DK) 2002-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 MAPK13 33/4885MAPK12 36/4885MAPK11 41/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.